fri, april 3 2020cmetracker.net/uva/files/brochures/136994.pdf · 2020-02-19 · updates in...

2
Program Overview This program will explore research and advances in the diagnosis and management of benign hematologic conditions and hematologic malignancies, including indications for novel therapies. Aimed at community hematologists and oncologists, as well as advanced practice providers and nurses, this meeting will use case-based presentations to highlight recommendations for treatment of common hematologic diagnoses. We will also discuss the role of health-related quality of life assessments in treatment planning. Learning Objectives As a result of participation in this symposium, attendees will be able to: • Explain the role of caplacizumab in the treatment of acute TTP • Apply systematic approaches in evaluation of patients with abnormal bleeding. • Select appropriate chemotherapy regimens for treatment of AML. • Discuss appropriate transfusion parameters for patients with malignancy-related cytopenias. • Apply health-related quality of life assessments in treatment planning to better address psychological needs of patients Provided by the Office of Continuing Medical Education, University of Virginia School of Medicine, and the School of Nursing Continuing Education Updates In Hematology and Hematologic Malignancies Kelly Davidson, MD Assistant Professor of Medicine Firas El Chaer, MD Assistant Professor of Medicine Laahn Foster, MD Assistant Professor of Medicine Michael K Keng, MD Assistant Professor of Medicine Thomas P Loughran, Jr, MD F. Palmer Weber-Smithfield Foods Professor of Oncology Research and Professor of Medicine; Director, UVA Cancer Center Louise Man, MD Assistant Professor of Medicine Holly Mellott, BSN, RN, CCM Clinical Care Coordinator Craig Portell, MD Associate Professor of Medicine Mary Souder, BSN, RN, OCN Clinical Care Coordinator Kathryn Strickler, MSN, RN, AG-PCNP Benign Hematology NP Indumathy Varadarajan, MD Assistant Professor of Medicine Michael E Williams, MD, ScM, FACP Byrd S. Leavell Professor of Medicine and Professor of Pathology; Chief, Hematology/Oncology Division; Physician Lead, UVA Cancer Service Line Planning Committee Gina DeGennaro, DNP, RN, CNS, AOCN Associate Professor of Nursing Elizabeth Patterson, MEd CME Program Manager Tanya Thomas, MSN, RN, AGCNS-BC, OCN Cancer Services, UVA Health Course Directors Karen Ballen, MD Professor of Medicine, Section Chief for Hematologic Malignancy and Stem Cell Transplant Hillary Maitland, MD, MS Associate Professor of Medicine Guest Faculty James D. Gorham, MD, PhD Chief, Division of Laboratory Medicine; Medical Director, Blood Bank and Transfusion Medicine Service Joanna S. Yost, PhD Assistant Professor of Psychiatry and Neurobehavioral Sciences, UVA Behavioral Medicine Center UVA Division of Hematology & Oncology Presenters Fri, Nov. 20 7:30am-4:30pm Omni Charlottesville Hotel 212 Ridge McIntire Road Charlottesville, VA 2020 Please visit www.cmevillage.com, Learning Portal to learn more about the 2020 UVA Cancer Center-Inova Schar Cancer Institute conference scheduled for Thursday, November 19, also at the Omni Charlottesville Hotel. We are offering a special discount for those who register for both programs. If interested in attending both programs, please contact [email protected] for your discount code BEFORE you register for the UVA-Inova Cancer conference.

Upload: others

Post on 24-May-2020

3 views

Category:

Documents


1 download

TRANSCRIPT

Program OverviewThis program will explore research and advances in the diagnosis and management of benign hematologic conditions and hematologic malignancies, including indications for novel therapies. Aimed at community hematologists and oncologists, as well as advanced practice providers and nurses, this meeting will use case-based presentations to highlight recommendations for treatment of common hematologic diagnoses. We will also discuss the role of health-related quality of life assessments in treatment planning.

Learning ObjectivesAs a result of participation in this symposium, attendees will be able to:• ExplaintheroleofcaplacizumabinthetreatmentofacuteTTP• Applysystematicapproachesinevaluationofpatientswithabnormalbleeding.• SelectappropriatechemotherapyregimensfortreatmentofAML.• Discussappropriatetransfusionparametersforpatientswithmalignancy-relatedcytopenias.• Applyhealth-relatedqualityoflifeassessmentsintreatmentplanningtobetteraddresspsychological

needs of patients

Provided by the Office of Continuing Medical Education, University of Virginia School of Medicine, and the School of Nursing Continuing Education

Updates In Hematology and HematologicMalignancies

Kelly Davidson, MDAssistantProfessorofMedicine

Firas El Chaer, MDAssistantProfessorofMedicine

Laahn Foster, MDAssistantProfessorofMedicine

Michael K Keng, MDAssistantProfessorofMedicine

Thomas P Loughran, Jr, MDF.PalmerWeber-SmithfieldFoodsProfessorofOncology Research andProfessorofMedicine;Director,UVACancer Center

Louise Man, MDAssistantProfessorofMedicine

Holly Mellott, BSN, RN, CCMClinical Care Coordinator

Craig Portell, MDAssociateProfessorofMedicine

Mary Souder, BSN, RN, OCNClinical Care Coordinator

Kathryn Strickler, MSN, RN, AG-PCNPBenign Hematology NP

Indumathy Varadarajan, MDAssistantProfessorofMedicine

Michael E Williams, MD, ScM, FACPByrdS.LeavellProfessorofMedicineandProfessorofPathology;Chief,Hematology/OncologyDivision;PhysicianLead,UVACancerServiceLine

Planning CommitteeGina DeGennaro, DNP, RN, CNS, AOCNAssociate Professor of Nursing

Elizabeth Patterson, MEdCMEProgramManager

Tanya Thomas, MSN, RN, AGCNS-BC, OCN CancerServices,UVAHealth

CourseDirectorsKaren Ballen, MD ProfessorofMedicine,SectionChiefforHematologicMalignancyandStemCellTransplant

Hillary Maitland, MD, MSAssociateProfessorofMedicine

Guest FacultyJames D. Gorham, MD, PhDChief,DivisionofLaboratoryMedicine;MedicalDirector,BloodBankandTransfusionMedicineService

Joanna S. Yost, PhDAssistant Professor of Psychiatry and NeurobehavioralSciences,UVABehavioralMedicineCenter

UVADivisionofHematology&OncologyPresenters

Fri, Nov. 207:30am-4:30pm

Omni Charlottesville Hotel212RidgeMcIntireRoad

Charlottesville,VA2020

Please visit www.cmevillage.com,LearningPortaltolearnmoreaboutthe2020UVACancerCenter-InovaScharCancer Institute conference scheduled for Thursday, November 19, also at the Omni Charlottesville Hotel. We are offering a special discount for those who register for both programs. If interested in attending both programs, please contactepatterson@virginia.eduforyourdiscountcodeBEFOREyouregisterfortheUVA-InovaCancerconference.

AccreditationandDesignationStatementsTheUniversityofVirginiaSchoolofMedi-cineisaccreditedbytheACCMEtoprovidecontinuing medical education for physi-cians.TheUniversityofVirginiaSchoolof

Medicinedesignatesthisliveactivityforamaximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.TheUniversityofVirginiaSchoolof

Medicine,asanaccreditedprovider,awards6.25 hours of participation (consis-tent with the designated number of AMA PRA Category 1 Credits™) to participants who successfully complete this educational activity.TheUniversityofVirginiaSchoolofMedicinemaintainsarecordofparticipa-tion for six (6) years.TheUniversityofVirginiaSchoolofNurs-

ingContinuingEducationisaccreditedasaprovider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.TheUniversityofVirginiaSONCEawards

6.25 contact hours for nurses who participate in this educational activity and complete the post activity evaluation.SuccessfulcompletionofthisCMEactivity

enables the participant to earn up to 6.25 MOC points in the American Board of InternalMedicine’s(ABIM)MaintenanceofCertification(MOC)program.ItistheCMEactivityprovider’sresponsibilitytosubmit participant completion information toACCMEforthepurposeofgrantingABIMMOCcredit.

Omni Charlottesville HoteA limited number of rooms are available onafirstcome,firstservedbasisattheOmni Charlottesville Hotel, located at 212 RidgeMcIntireRd,attheendofthehistoricDowntownMall.Attendeeswillneedtomaketheirownreservationsusingthegroupname “Updates in Hematology 2020” to receive the group rate of $169+ taxes/fees, withcomplimentaryparking.

Reserve rooms by calling the hotel directly at(434)971-5500orusethislink: https://www.omnihotels.com/hotels/charlot-tesville/meetings/uva-updates-in-he-matology-11192020BlockclosesonOctober5,2020.

Contact InformationElizabeth K Patterson, MEdProgramManager,OfficeofContinuingMedicalEducationepatterson@virginia.edu434-924-5310

Registration and FeesOnline registration and payment available at www.cmevillage.com (click<LearningPortal>) or

Registrationfees(includingonlinesyllabus,breakfast,lunch,andbreakrefreshments)•Physicians............................. $220 (walk-inregistration$320)•NPs,PAs,Nurses,Fellows ..... $95 (walk-inregistration$195) &OtherHealthProfessionals

Online registration closes 11/13/20. *Syllabus will be provided online at www.cmevillage.com, “Syllabus”

Attention UVA Faculty and Staff:ForinfoaboutapplyingforreimbursementusingyourUVAeducationalbenefit,visit:https://hr.virginia.edu/career-development/education-benefits

ConfirmationandCancellationPolicyUponreceiptofregistrationandpayment,youwillreceiveanemailconfirmationandEPayreceipt.Pleasekeepthisconfirmationforyourrecords.Registrationfeeswillbe refunded (less a $50 administrative fee) for written email cancellations received a minimum of 14 days prior to the activity date. No refunds may be granted for cancel-lations made within 13 days of the activity.

AGENDA7:30 - 8:30 BreakfastandRegistration

8:30 - 8:35 IntroandWelcome Loughran/Maitland

8:35 - 10:25 HEMATOLOGY 8:35 ThromboticThrombocytopenic KellyDavidson

Purpura9:00 Evaluationofbleeding LouiseMan9:25 TBD10:10 Panel Davidson,Man,

KathrynStrickler

10:25 -10:40 Break

10:40 - 12:35 MYELOIDMALIGNANCY 10:40 AcuteMyeloidLeukemia MichaelKeng 11:05 MyeloproliferativeNeoplasms FirasElChaer 11:30 CART InduVaradarajan 11:55 Panel Keng,ElChaer,Mary

Souder,Varadarajan

12:10 - 1:00 Lunch provided

1:00 - 2:15 SUPPORTIVECARE 1:00 MentalHealth JoannaYost1:30 Transfusion JamesGorham2:00 Panel Yost,Gorham,

2:15 - 4:20 LYMPHOIDMALIGNANCY 2:15 UpdatesinCLL:OptimizingUse CraigPortell

of Targeted Therapies 2:40 Myeloma LaahnFoster

3:05 - 3:20 Break3:20 Mantlecelllymphoma:30years MichaelWilliams

of progress 4:05 Panel Portell, Foster,

Williams,HollyMellott

4:20 - 4:30 Closing Maitland,Ballen

REGISTER